000			02229 a2200565 4500
005			20250517233656.0
264		0	_c20191125
008			201911s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdy326 _2doi
040			_aNLM _beng _cNLM
100	1		_aThomas, M
245	0	0	_aImmunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _c10 2018
300			_a2076-2084 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aImmunotherapy
650	0	4	_aInternational Agencies
650	0	4	_aLeflunomide _xtherapeutic use
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMaintenance Chemotherapy
650	0	4	_aPrognosis
650	0	4	_aSmall Cell Lung Carcinoma _xdrug therapy
650	0	4	_aSurvival Rate
650	0	4	_aToll-Like Receptor 9 _xagonists
700	1		_aPonce-Aix, S
700	1		_aNavarro, A
700	1		_aRiera-Knorrenschild, J
700	1		_aSchmidt, M
700	1		_aWiegert, E
700	1		_aKapp, K
700	1		_aWittig, B
700	1		_aMauri, C
700	1		_aDómine Gómez, M
700	1		_aKollmeier, J
700	1		_aSadjadian, P
700	1		_aFröhling, K-P
700	1		_aHuber, R M
700	1		_aWolf, M
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 10 _gp. 2076-2084
856	4	0	_uhttps://doi.org/10.1093/annonc/mdy326 _zAvailable from publisher's website
999			_c28758828 _d28758828